A research team led by the Hebrew University of Jerusalem have boosted the immune system’s cancer-fighting ability by reprogramming. They disabled the mitochondrial protein Ant2 in T cells, forcing them to produce more energy and become stronger and better at … Continue reading →

Scientists from Sheba Medical Center and Tel Aviv University have taken human kidney tissue stem cells and grown a 3D organ culture (organoids) to 34 weeks maturity – the longest-lasting and purest ever developed. It will advance research into kidney … Continue reading →

Researchers at Sheba Medical Center have sent a groundbreaking scientific experiment to the International Space Station (ISS). It will study how space conditions – especially microgravity – influence bacterial virulence and resistance to antibiotics. https://www.timesofisrael.com/israeli-experiment-on-bacteria-heads-to-international-space-station/

An Israeli-led team has been awarded a $1.2 million grant by the prestigious Human Frontier Science Program (HFSP). It will study epigenetic inheritance –traits acquired from the environment can be passed to descendants. This research begun by Jewish scientists came … Continue reading →

Meet 8 Israeli AgeTech medical startups at UCLA. Lunchtime on Aug 12. Buzzy, Effectivate, Eyeclick, Kemtai, Opmed.ai, Physiclean, Quai.MD & ROBE-Health.  RSVP [email protected] asap, if you wish to attend. Dietary laws observed. https://www.dropbox.com/scl/fi/76dj8o6ecw5mkm6p7a5ci/Agetech-and-Rehabilitation-Delegation-West-Coast-Catalog.pdf?rlkey=dr8bo0tkvk5f1kn699l3rxkec&e=1&dl=0 https://www.buzzyplatform.com/ https://effectivate.com/ https://physiclean.com/ https://robe-health.com/

Israel’s C2A Security (see here previously) has partnered with US-based Medcrypt to integrate their security protection facilities. It ensures that every software component and artifact in a medical device is traceable, authenticated, and tamper-proof, from development through post-market updates. https://www.ourcrowd.com/startup-news/c2a-security-and-medcrypt-forge-partnership-to-elevate-medical-device-security

Researchers at Israel’s Weimann Institute have diagnosed a rare genetic disease that delays child development. Sufferers are missing the gene Chaserr which controls CHD2 protein production. Too much CHD2 causes the disease; too little CHD2 is linked to autism and … Continue reading →